Citation Impact
Citing Papers
Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Signal transduction to hypoxia-inducible factor 1
2002 StandoutNobel
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
2004 Standout
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer
2006
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
2015 StandoutNobel
Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs
2002 StandoutNobel
Treatment of kidney cancer
2009 StandoutNobel
c- erb B-2 Related Aggressiveness in Breast Cancer Is Hypoxia Inducible Factor-1α Dependent
2004
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
2001
Association of hypoxia‐inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma
2002
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Nasopharyngeal carcinoma
2005 Standout
Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
2011
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
2008 StandoutNobel
HIF-1 and tumor progression: pathophysiology and therapeutics
2002 StandoutNobel
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Lung Cancer
2008 Standout
Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance
2007
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus
2008
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor
2016
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications
2008
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer
2002
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Diabetes in Asia
2009 Standout
The Antiangiogenic Agents SU5416 and SU6668 Increase the Antitumor Effects of Fractionated Irradiation
2002
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Curcumin: The story so far
2005 Standout
Regulation of mucin expression: Mechanistic aspects and implications for cancer and inflammatory diseases
2006
Nasopharyngeal carcinoma
2015 Standout
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression
2017
The relation between hypoxia‐inducible factor (HIF)‐1α and HIF‐2α expression with anemia and outcome in surgically treated head and neck cancer
2006
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer
2005
MUC1 expression in human prostate cancer cell lines and primary tumors
2004
Angiogenesis as a biomarker and target in cancer chemoprevention
2001
The Role of the Lymphatic System in Endometriosis: A Comprehensive Review of the Literature1
2015
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells
2011 StandoutNobel
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
The emerging roles of human tissue kallikreins in cancer
2004
Expression of sialylated MUC1 in prostate cancer: Relationship to clinical stage and prognosis
2005
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
2003
Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer
2004
Prostate cancer invasion and metastasis: insights from mining genomic data
2013
Macrophage activation and polarization
2007 Standout
HIF and the Lung
2011 StandoutNobel
Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype
2014 StandoutNobel
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation
2005
Role of angiogenesis in tumor growth and metastasis
2002 Standout
Diabetes and Cancer
2010 Standout
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Antiangiogenic Strategies and Agents in Clinical Trials
2000
Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration.
2003
Sunflower trypsin inhibitor (SFTI-1) analogues of synthetic and biological origin via N→S acyl transfer: potential inhibitors of human Kallikrein-5 (KLK5)
2014 StandoutNobel
Endometriosis
2020 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
2003
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
2004
Macrophage plasticity and polarization in tissue repair and remodelling
2012 Standout
Regulation of angiogenesis by hypoxia-inducible factor 1
2006 StandoutNobel
Works of E Sivridis being referenced
Hypoxia inducible factor 1 alpha and 2 alpha expression is independent of anemia in patients with stage I endometrial cancer.
2003
LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer: Figure 1
2005
Endometrial carcinoma and diabetes revisited.
2006
Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
1999
Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer.
2001
Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
2000
Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy.
2002